SFRP2 and colorectal carcinoma: To guide the treatment strategy for individual CRC patients more accurately, we constructed a cuproptosis prognostic model resulting in the recruitment of five genes (HES4, SPHK1, TNNT1, HOXC6, and SFRP2).